2 news items
Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
MBRX
9 May 24
patent, Moleculin has additional patent applications related to Annamycin pending in the U.S. and in major jurisdictions
Moleculin Announces U.S. Patent Issue Notification for Annamycin Targeting Unmet Need in AML
MBRX
27 Mar 24
technology. In addition to the expected '118 patent, Moleculin has additional patent applications pending in the U.S. and in major jurisdictions
- Prev
- 1
- Next